Pharmacy

• An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? (27 Sep 2024)
  
• Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions (23 Sep 2024)
  
• Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria (16 Sep 2024)
  
• Pharmacology and drug interactions of cannabinoids (16 Sep 2024)
  
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology (02 Sep 2024)
  
• Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
  
• CANNabinoid Drug Interaction Review (CANN-DIR™) (28 Aug 2024)
  
• A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
  
• Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs (31 Jul 2022)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)
  
• How to use CBD & Cannabis (20 Jul 2022)
  
• CBIS Cannabinoid Research (20 Jul 2022)
  
• Cannabis Therapy for Seizures in Animals (20 Jul 2022)
  
• Tablet containing CBD shows promise in reducing post-operative pain (18 Jul 2022)